EcoDrugPlus

Muscarinic Acetylcholine Receptor M5-Like

Ensembl ID : ENSOTSG00005012355
Gene Symbol: LOC112233138
3 Cross references
188 Possible Orthologues:

Muscarinic Acetylcholine Receptor M5-Like

Ensembl ID : ENSOTSG00005042925
Gene Symbol: LOC112233138
3 Cross references
188 Possible Orthologues:

Natriuretic Peptide Receptor 1a

Ensembl ID : ENSOTSG00005042723
Gene Symbol: NPR1A
1 Cross references
186 Possible Orthologues:

Natriuretic Peptide Receptor 3

Ensembl ID : ENSOTSG00005040592
Gene Symbol: NPR3
1 Cross references
206 Possible Orthologues:

Neurogenic Locus Notch Homolog Protein 1-Like

Ensembl ID : ENSOTSG00005023839
Gene Symbol: LOC112219708
3 Cross references
196 Possible Orthologues:

Neuromedin-K Receptor-Like

Ensembl ID : ENSOTSG00005031869
Gene Symbol: LOC112257220
3 Cross references
190 Possible Orthologues:

Neuromedin-K Receptor-Like

Ensembl ID : ENSOTSG00005001838
Gene Symbol: LOC112262409
3 Cross references
242 Possible Orthologues:

Neuropeptide Y Receptor Y2

Ensembl ID : ENSOTSG00005001323
Gene Symbol: NPY2R
3 Cross references
178 Possible Orthologues:

Neuropeptide Y Receptor Y2

Ensembl ID : ENSOTSG00005006738
Gene Symbol: NPY2R
1 Cross references
178 Possible Orthologues:

Neurotensin Receptor 1

Ensembl ID : ENSOTSG00005009563
Gene Symbol: NTSR1
3 Cross references
197 Possible Orthologues:

Neurotensin Receptor 1

Ensembl ID : ENSOTSG00005002847
Gene Symbol: NTSR1
1 Cross references
198 Possible Orthologues:

Neurotrophic Receptor Tyrosine Kinase 2

Ensembl ID : ENSOTSG00005044742
Gene Symbol: NTRK2
1 Cross references
202 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).